Repurposing Benztropine, Natamycin, and Nitazoxanide Using Drug Combination and Characterization of Gastric Cancer Cell Lines
暂无分享,去创建一个
A. Maurício | F. Faria | N. Vale | A. Rêma | Mariana Pereira | R. Alvites | A. Sousa | I. Amorim | Bruna Lopes | Patrícia Sousa | Diana Araújo | B. Porto | Cláudia Oliveira | Eduarda Ribeiro | André Coelho
[1] N. Vale,et al. Drug Repurposing in Cancer Therapy: Influence of Patient’s Genetic Background in Breast Cancer Treatment , 2022, International journal of molecular sciences.
[2] A. Jha,et al. A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19 , 2022, COVID.
[3] N. Vale,et al. Drug Combinations: A New Strategy to Extend Drug Repurposing and Epithelial-Mesenchymal Transition in Breast and Colon Cancer Cells , 2022, Biomolecules.
[4] P. Xia,et al. Reversine inhibits proliferation, invasion and migration and induces cell apoptosis in gastric cancer cells by downregulating TTK , 2021, Experimental and therapeutic medicine.
[5] N. El-Najjar,et al. Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know? , 2021, Cancers.
[6] C. Kundu,et al. 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[7] A. Kesselheim,et al. Repurposing existing drugs for new uses: a cohort study of the frequency of FDA-granted new indication exclusivities since 1997 , 2021, Journal of pharmaceutical policy and practice.
[8] B. Bedogni,et al. Wound Healing Assay for Melanoma Cell Migration. , 2021, Methods in molecular biology.
[9] M. Kook,et al. Predictive value of E-cadherin and EpCAM for detection of metastatic lymph node in early gastric cancer , 2020, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.
[10] A. Mostafa,et al. Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19? , 2020, Journal of Genetic Engineering and Biotechnology.
[11] E. Nice,et al. Overcoming cancer therapeutic bottleneck by drug repurposing , 2020, Signal Transduction and Targeted Therapy.
[12] G. Monteleone,et al. Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System , 2020, International journal of molecular sciences.
[13] K. Tao,et al. A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer , 2020, OncoTargets and therapy.
[14] M. Takigawa,et al. Antiparkinson Drug Benztropine Suppresses Tumor Growth, Circulating Tumor Cells, and Metastasis by Acting on SLC6A3/DAT and Reducing STAT3 , 2020, Cancers.
[15] Jamie N. Brown,et al. Treatment of Helicobacter pylori with nitazoxanide-containing regimens: a systematic review , 2020, Infectious diseases.
[16] W. González,et al. TASK-3 Gene Knockdown Dampens Invasion and Migration and Promotes Apoptosis in KATO III and MKN-45 Human Gastric Adenocarcinoma Cell Lines , 2019, International journal of molecular sciences.
[17] I. Agoulnik,et al. Inhibition of base excision repair by natamycin suppresses prostate cancer cell proliferation. , 2019, Biochimie.
[18] Maria Sofia Fernandes,et al. Clinical spectrum and pleiotropic nature of CDH1 germline mutations , 2019, Journal of Medical Genetics.
[19] Allen W. Zhang,et al. Cancer stemness, intratumoral heterogeneity, and immune response across cancers , 2018, Proceedings of the National Academy of Sciences.
[20] Yan Gao,et al. Establishment and characterization of a GES-1 human gastric epithelial cell line stably expressing miR-23a , 2018, Oncology letters.
[21] Mingfei Wang,et al. Effects of glabridin combined with 5-fluorouracil on the proliferation and apoptosis of gastric cancer cells , 2018, Oncology letters.
[22] N. André,et al. Drug repurposing in malignant pleural mesothelioma: a breath of fresh air? , 2018, European Respiratory Review.
[23] M. Ritter,et al. Miniaturization of the Clonogenic Assay Using Confluence Measurement , 2018, International journal of molecular sciences.
[24] Z. Kavosi,et al. Risk Factors for Gastric Cancer: A Systematic Review , 2018, Asian Pacific journal of cancer prevention : APJCP.
[25] S. Papapetropoulos,et al. Drug repurposing from the perspective of pharmaceutical companies , 2018, British journal of pharmacology.
[26] K. Kalland,et al. Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer. , 2018, Nature chemical biology.
[27] Michael Pryszlak,et al. Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics , 2017, Front. Oncol..
[28] A. German,et al. Gastric carcinoma in canines and humans, a review , 2017, Veterinary and comparative oncology.
[29] Yuanyu Wu,et al. Progress in the treatment of advanced gastric cancer , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[30] F. Safari,et al. Evaluation of Cell- Morphological Changes by Helicobacter pylori CagA and Pragmin in AGS Human Gastric Carcinoma Cells , 2017 .
[31] A. Kaur,et al. Wound Healing Concepts in Clinical Practice of OMFS , 2017, Journal of Maxillofacial and Oral Surgery.
[32] Jin-bo Gao,et al. Molecular mechanisms of chemoresistance in gastric cancer , 2016, World journal of gastrointestinal oncology.
[33] Qi Zhang,et al. Preclinical pharmacodynamic evaluation of antibiotic nitroxoline for anticancer drug repurposing , 2016, Oncology letters.
[34] L. Qu,et al. Nuclear transcription factor CDX2 inhibits gastric cancer‑cell growth and reverses epithelial‑to‑mesenchymal transition in vitro and in vivo. , 2015, Molecular medicine reports.
[35] J. Sweasy,et al. Gastric cancer associated variant of DNA polymerase beta (Leu22Pro) promotes DNA replication associated double strand breaks , 2015, Oncotarget.
[36] Yun-En Liu,et al. NaCl pretreatment attenuates H.pylori-induced DNA damage and exacerbates proliferation of gastric epithelial cells (GES-1) , 2015, Infectious Agents and Cancer.
[37] Ling Huang,et al. 5-Fluorouracil Chemotherapy of Gastric Cancer Generates Residual Cells with Properties of Cancer Stem Cells , 2015, International journal of biological sciences.
[38] J. Black,et al. Nitazoxanide Use as Part of an Empiric Multi-Drug Regimen in Treating Children with Suspected Helicobacter pylori Infection , 2014, Case Reports in Gastroenterology.
[39] Kuan-song Wang,et al. Epidermal Growth Factor-Like Domain-Containing Protein 7 (EGFL7) Enhances EGF Receptor−AKT Signaling, Epithelial−Mesenchymal Transition, and Metastasis of Gastric Cancer Cells , 2014, PloS one.
[40] S. Gambhir,et al. A c-Myc Activation Sensor-Based High-Throughput Drug Screening Identifies an Antineoplastic Effect of Nitazoxanide , 2013, Molecular Cancer Therapeutics.
[41] M. Rezaei-Tavirani,et al. Flow Cytometry Analysis of Rosa Damascena Effects on Gastric Cancer Cell Line (MKN45) , 2013 .
[42] W. El-Rifai,et al. Silencing of Glutathione Peroxidase 3 through DNA Hypermethylation Is Associated with Lymph Node Metastasis in Gastric Carcinomas , 2012, PloS one.
[43] S. Cai,et al. Tumor‐associated macrophages promote angiogenesis and lymphangiogenesis of gastric cancer , 2012, Journal of surgical oncology.
[44] N. Shah,et al. A Randomized Study Comparing Levofloxacin, Omeprazole, Nitazoxanide, and Doxycycline versus Triple Therapy for the Eradication of Helicobacter pylori , 2011, The American Journal of Gastroenterology.
[45] J. Bussink,et al. Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[46] N. Sarma,et al. Colony forming cell (CFC) assay for human hematopoietic cells. , 2010, Journal of visualized experiments : JoVE.
[47] Sylvia E. Le Dévédec,et al. Systems microscopy approaches to understand cancer cell migration and metastasis , 2010, Cellular and Molecular Life Sciences.
[48] R. Huang,et al. Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.
[49] J. Wastling,et al. Thiazolides inhibit growth and induce glutathione‐S‐transferase Pi (GSTP1)‐dependent cell death in human colon cancer cells , 2008, International journal of cancer.
[50] Ning Zhang,et al. 5-Fluorouracil: Mechanisms of Resistance and Reversal Strategies , 2008, Molecules.
[51] H. Riezman,et al. Natamycin Blocks Fungal Growth by Binding Specifically to Ergosterol without Permeabilizing the Membrane* , 2008, Journal of Biological Chemistry.
[52] D. Weiss. Chapter 11 – Neutrophil Function , 2008 .
[53] Goberdhan P Dimri,et al. Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay. , 2007, Methods in molecular biology.
[54] B. Madras,et al. Dopamine Transporter (DAT) Inhibitors Alleviate Specific Parkinsonian Deficits in Monkeys: Association with DAT Occupancy in Vivo , 2006, Journal of Pharmacology and Experimental Therapeutics.
[55] S. Runyon,et al. Dopamine transporter ligands: recent developments and therapeutic potential. , 2006, Current topics in medicinal chemistry.
[56] A. Neugut,et al. Epidemiology of gastric cancer. , 2006, World journal of gastroenterology.
[57] J. Haveman,et al. Clonogenic assay of cells in vitro , 2006, Nature Protocols.
[58] P. Johnston,et al. 5-Fluorouracil: mechanisms of action and clinical strategies , 2003, Nature Reviews Cancer.
[59] K. Walen. The origin of transformed cells. studies of spontaneous and induced cell transformation in cell cultures from marsupials, a snail, and human amniocytes. , 2002, Cancer genetics and cytogenetics.
[60] K. Kinzler,et al. Genetic instabilities in human cancers , 1998, Nature.
[61] K. Kinzler,et al. Genetic instability in colorectal cancers , 1997, Nature.
[62] R. Moll,et al. Synaptophysin: a marker protein for neuroendocrine cells and neoplasms. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[63] T. Motoyama,et al. COMPARISON OF SEVEN CELL LINES DERIVED FROM HUMAN GASTRIC CARCINOMAS , 1986, Acta pathologica japonica.
[64] C. Heidelberger,et al. Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory Compounds , 1957, Nature.
[65] J.. Diagnostic Immunohistochemistry , 2022 .